M Virji
Overview
    Explore the profile of M Virji including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              74
            
            
              Citations
              2110
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Virji M, Serino L
  
  
    Methods Mol Med
    . 2011 Feb;
          67:599-619.
    
    PMID: 21337168
  
  
          Neisseria meningitidis is a human specific pathogen and resides primarily in the nasopharynx of its host. The molecular-recognition mechanisms that operate at the host-microbe interface to impart such precise host/tissue...
      
2.
        
    
    Horton R, Vidarsson G, Virji M, Williams N, Heyderman R
  
  
    Microb Pathog
    . 2009 Jun;
          46(5):253-60.
    
    PMID: 19486642
  
  
          Despite high carriage rates of Neisseria meningitidis, incidence of meningococcal disease remains low, partially due to development of natural immunity. We have previously demonstrated an inverse relationship between salivary anti-meningococcal...
      
3.
        
    
    Strauss K, Mazariegos G, Sindhi R, Squires R, Finegold D, Vockley G, et al.
  
  
    Am J Transplant
    . 2006 Feb;
          6(3):557-64.
    
    PMID: 16468966
  
  
          An 8.5-year-old girl with classical maple syrup urine disease (MSUD) required liver transplantation for hypervitaminosis A and was effectively cured of MSUD over an 8-year clinical follow-up period. We developed...
      
4.
        
    
    Beauchemin N, Draber P, Dveksler G, Gold P, Grunert F, Hammarstrom S, et al.
  
  
    Exp Cell Res
    . 2001 Aug;
          252(2):243-9.
    
    PMID: 11501563
  
  
          No abstract available.
      
5.
        
    
    Virji M, Carter J, LIRENMAN D
  
  
    Pediatr Transplant
    . 2001 Jul;
          5(4):293-6.
    
    PMID: 11472609
  
  
          Mycophenolate mofetil (MMF), a potent and specific inhibitor of guanosine nucleotide synthesis, is a new immunosuppressive drug used to prevent rejection in transplant patients. Extensive data on its utility and...
      
6.
        
                      7.
        
    
    Venkataramanan R, Shaw L, Sarkozi L, Mullins R, Pirsch J, Macfarlane G, et al.
  
  
    J Clin Pharmacol
    . 2001 May;
          41(5):542-51.
    
    PMID: 11361051
  
  
          The relationship between the dose of tacrolimus, trough tacrolimus blood concentration, and selected clinical endpoints (acute rejection, nephrotoxicity, and other toxicities) were examined in a prospective, multicenter clinical trial to...
      
8.
        
    
    Hill D, Toleman M, Evans D, Villullas S, van Alphen L, Virji M
  
  
    Mol Microbiol
    . 2001 Mar;
          39(4):850-62.
    
    PMID: 11251807
  
  
          Haemophilus influenzae, a commensal of the human respiratory mucosa, is an important cause of localized and systemic infections. We have recently shown that numerous strains of capsulate (typeable) and acapsulate...
      
9.
        
    
    Toleman M, Aho E, Virji M
  
  
    Cell Microbiol
    . 2001 Feb;
          3(1):33-44.
    
    PMID: 11207618
  
  
          Several species of commensal Neisseriae (Cn) may colonize the human nasopharynx, but little is known about their adhesion mechanisms. We have investigated structural and functional similarities between adhesins of Cn...
      
10.